Infectious Diseases (except HIV/AIDS)

  1. SARS-CoV-2 Cross-Reactivity in Prepandemic Serum from Rural Malaria-Infected Persons, Cambodia

    1. Jessica Manning
    2. Irfan Zaidi
    3. Chanthap Lon
    4. Luz Angela Rosas
    5. Jae-Keun Park
    6. Aiyana Ponce
    7. Jennifer Bohl
    8. Sophana Chea
    9. Maria Karkanitsa
    10. Sokunthea Sreng
    11. Huy Rekol
    12. Char Meng Chour
    13. Dominic Esposito
    14. Jeffery K. Taubenberger
    15. Matthew J. Memoli
    16. Kaitlyn Sadtler
    17. Patrick E. Duffy
    18. Fabiano Oliveira

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. A standardized instrument quantifying risk factors associated with bi-directional transmission of SARS-CoV-2 and other zoonotic pathogens: The COVID-19 human-animal interactions survey (CHAIS)

    1. Jonathon D. Gass
    2. Kaitlin B. Waite
    3. Nichola J. Hill
    4. Kathryn R. Dalton
    5. Kaitlin Sawatzki
    6. Jonathan A. Runstadler
    7. Meghan F. Davis

    Reviewed by ScreenIT

    1 evaluationAppears in 2 listsLatest version Latest activity

  3. Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study

    1. Marit J. van Gils
    2. Ayesha Lavell
    3. Karlijn van der Straten
    4. Brent Appelman
    5. Ilja Bontjer
    6. Meliawati Poniman
    7. Judith A. Burger
    8. Melissa Oomen
    9. Joey H. Bouhuijs
    10. Lonneke A. van Vught
    11. Marleen A. Slim
    12. Michiel Schinkel
    13. Elke Wynberg
    14. Hugo D. G. van Willigen
    15. Marloes Grobben
    16. Khadija Tejjani
    17. Jacqueline van Rijswijk
    18. Jonne L. Snitselaar
    19. Tom G. Caniels
    20. Amsterdam UMC COVID-19 S3/HCW study group
    21. Alexander P. J. Vlaar
    22. Maria Prins
    23. Menno D. de Jong
    24. Godelieve J. de Bree
    25. Jonne J. Sikkens
    26. Marije K. Bomers
    27. Rogier W. Sanders

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Induction of robust neutralizing antibodies against the COVID-19 Delta variant with ChAdOx1 nCoV-19 or BNT162b2 as a booster following a primary vaccination series with CoronaVac

    1. Samadhi Patamatamkul
    2. Sutthiwan Thammawat
    3. Benjaporn Buranrat

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Large-scale seroepidemiologic surveillance of COVID-19 - Cross-sectional study in Hyogo prefecture of Japan in August, 2021

    1. Zhenxiao Ren
    2. Koichi Furukawa
    3. Mitsuhiro Nishimura
    4. Yukiya Kurahashi
    5. Silvia Sutandhio
    6. Lidya Handayani Tjan
    7. Kaito Aoki
    8. Natsumi Hasegawa
    9. Jun Arii
    10. Kenichi Uto
    11. Keiji Matsui
    12. Itsuko Sato
    13. Jun Saegusa
    14. Nonoka Godai
    15. Kohei Takeshita
    16. Masaki Yamamoto
    17. Tatsuya Nagashima
    18. Yasuko Mori

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. COVID-19 Vaccine Breakthrough Infections in Veterans Health Administration

    1. Aditya Sharma
    2. Gina Oda
    3. Mark Holodniy

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Age-Specific Changes in Virulence Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern

    1. David N Fisman
    2. Ashleigh R Tuite

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Evaluation of a new “all in one” SARS‐CoV‐2 antigen‐detecting rapid diagnostic test and self‐test: Diagnostic performance and usability in child and adult populations

    1. Thierry Prazuck
    2. Anne Gravier
    3. Daniela Pires‐Roteira
    4. Aurelie Theillay
    5. Sandra Pallay
    6. Mathilda Colin
    7. Raphael Serreau
    8. Laurent Hocqueloux
    9. Nino Guy Cassuto

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Antibody titers against the Alpha, Beta, Gamma, and Delta variants of SARS-CoV-2 induced by BNT162b2 vaccination measured using automated chemiluminescent enzyme immunoassay

    1. Hideaki Kato
    2. Kei Miyakawa
    3. Norihisa Ohtake
    4. Hirofumi Go
    5. Yutaro Yamaoka
    6. Satoshi Yajima
    7. Tomoko Shimada
    8. Atsushi Goto
    9. Hideaki Nakajima
    10. Akihide Ryo

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs

    1. Chiara Ronchini
    2. Sara Gandini
    3. Sebastiano Pasqualato
    4. Luca Mazzarella
    5. Federica Facciotti
    6. Marina Mapelli
    7. IEO Covid Team
    8. Gianmaria Frige’
    9. Rita Passerini
    10. Luca Pase
    11. Silvio Capizzi
    12. Fabrizio Mastrilli
    13. Roberto Orecchia
    14. Gioacchino Natoli
    15. Pier Giuseppe Pelicci

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 291 of 716 Next